MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Prepaid expenses andother current assets$38,917 Cash and cashequivalents$11,709 Operating leaseright-of-use asset$129,519 Total current assets$50,626 Other assets$8,132 Property and equipment,net$8,066 Total assets$196,343 Accumulated deficit-$54,274,421 Treasury stock, 47,861shares, at cost, at march...$150,000 Total liabilities andstockholders deficit$196,343 Total stockholdersdeficit-$2,841,648 Additional paid-in capital$51,579,029 Convertible preferredstock, value-Series...$2,381 Common stock, 0.0001par value,...$704 Convertible preferredstock, value-Series...$659 Total liabilities$3,037,991 Total currentliabilities$3,027,696 Operating leaseliability, net of current...$10,295 Notes payable relatedparties$1,625,000 Accrued expenses andother current...$594,723 Accounts payable$547,829 Accrued interest related parties$139,100 Operating lease liability current portion$121,044
Balance Sheet

Lakewood-Amedex Biotherapeutics Inc. (LABT)

Lakewood-Amedex Biotherapeutics Inc. (LABT)

source: myfinsight.com